Prescription drug · ANDA
midazolam (midazolam hydrochloride) NDC 25021-661
Midazolam hydrochloride 5 mg/mL · Injection, Solution · Intramuscular, Intravenous · Sagent Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 25021-661-10 | 25021066110 | 10 VIAL in 1 CARTON (25021-661-10) / 10 mL in 1 VIALMarketed from Mar 19, 2012 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- midazolam
- Generic name (nonproprietary)
- midazolam hydrochloride
- Active ingredients
- Midazolam hydrochloride — 5 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Labeler
- Sagent Pharmaceuticals
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090850
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 25021-661_002ea282-09ba-4d79-8bd1-94c9859f442bSPL ID 002ea282-09ba-4d79-8bd1-94c9859f442bSPL set ID 880cac48-5c0f-49a9-8aef-3c9770bf5d84RxCUI 311702UNII W7TTW573JJ
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N425021066110followed by a unit qualifier and the quantityPackage 25021-0661-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Midazolam Injection is indicated: intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia; intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other CNS depressants; intravenously for induction of general anesthesia, before administration of other anesthetic agents. With the use of narcotic premedication, induction of anesthesia can be attained within a relative…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090850
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Midazolam Hydrochloride | Midazolam hydrochloride 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | Gland Pharma Limited | 68083-108 |
| Midazolam Hydrochloride | Midazolam hydrochloride 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | Jvet Pharmaceuticals LLC | 86211-111 |
| Midazolam hydrochloride | Midazolam hydrochloride 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-601 |
| Midazolam Hydrochloride | Midazolam hydrochloride 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | Belcher Pharmaceuticals, LLC | 62250-111 |